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 The Cytochrome P450 family is a class of enzymes responsible for the breakdown 
of about 75% of the drugs that are administered (18). The 2E1 isoform of this family is 
known as the “ethanol-inducible” member, because ethanol has demonstrated the 
capacity to affect the metabolism of other 2E1 substrates (15, 16). It has been proposed 
that elevated concentrations of ethanol in the liver are responsible for the activation of 
acetaminophen and nitrosamine constituents found in cigarette smoke into hepatotoxic 
byproducts, and that an increase in polarity in a very hydrophobic active site may have a 
significant role in perpetuating these toxic effects (2-3, 23). In the present study, the 
objective was to probe the influence of ethanol and subsequently, increased active site 
polarity, on the catalytic scheme of other P4502E1 substrates. Additionally, due to the fact 
that many other P450 isoforms contain hydrophobic active sites and therefore, may also 
be affected by changing polarity in the active site environment, the implications of these 
studies were evaluated in the context of the P450 family as a whole.   
Potential evidence regarding the existence of an effector site adjacent to the 
catalytic site, and its role in 2E1 catalysis, was also probed. Designed to examine the 
effect of ethanol on the previously observed substrate inhibition pattern in p-nitrophenol 
oxidation, results from current studies indicated that ethanol potentially disrupts ligand-
ligand interactions between the catalytic and effector sites. The ability of ethanol to 
potentially alter rate-limiting steps in 2E1-mediated benzyl alcohol oxidation was 
explored through intrinsic isotope effect studies. Despite being limited by the purity of 
the benzyl alcohol substrate, an apparent shift or “unmasking” of the isotope effect was 
observed when ethanol was added. Finally, reversibility studies were carried out to 
evaluate the capacity of ethanol to interfere with 2E1 inactivation by 4-
nitrobenzaldehyde, a potent irreversible inhibitor of the 2B4 isoform (7). When ethanol 
was present in low concentrations, a synergistic effect was exhibited, where the activity 
of 2E1 was reduced to an even greater degree than reactions containing the aldehyde 
alone. An increase in enzyme activity was observed in reactions containing the aldehyde 
and higher concentrations of ethanol, relative to those containing only the aldehyde, 
suggesting that ethanol exerted a pseudo-protective effective in this case.  
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CHAPTER I 
 
INTRODUCTION 
 
 
Cytochrome P450 enzymes, a class of monooxygenases that play an important 
role in the metabolism of various xenobiotic compounds, have been studied at length in 
order to obtain more detailed models of the mechanisms involved in catalysis. Different 
isoforms of the enzyme are identified by their substrate specificity and mechanism of 
catalysis, and are of high interest in the study of drug-drug interactions in the human 
body (1-3). Details concerning oxidative mechanisms and substrate selectivity for the 
2E1 isoform have been elusive, and a lack of knowledge in this area has limited the 
overall potential of the isoform as a therapeutic target. Our investigation focused on 
elucidating further mechanistic details in 2E1 catalysis, particularly the effects of ethanol 
on catalysis. 
 To extract further mechanistic details, studies were carried out to observe the 
effect of ethanol on the substrate inhibition pattern previously seen with para-nitrophenol 
(PNP). The role of a recently proposed “effector site” existing distal to the active site, 
was also probed in these studies (4). Assuming that ethanol competes for binding within 
the active site, a shift in substrate inhibition pattern for PNP should be evident. We were 
able to observe this shift at different concentrations of ethanol, and the implications of 
this observation will be discussed. 
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In addition, the ability of ethanol to influence observed isotope effects in the 2E1-
mediated oxidation of benzyl alcohol, by changing active site polarity, was evaluated. 
Because the active site of P4502E1 is very hydrophobic in nature, we proposed that an 
increased concentration of ethanol may lead to alterations in the precise mechanism for 
benzyl alcohol oxidation by this isoform. The C-H bond-breaking step is associated with 
a substantial activation barrier, and large isotope effects (KIE > 7) have been observed 
when this step is rate-limiting (5, 6). However, increases in active site polarity may 
change the energetics of this process, whereby O-H bond activation becomes the favored 
process. Thus, we have investigated the effect of increasing ethanol concentration and 
active site polarity on the intrinsic isotope effect of benzyl alcohol, which serves to probe 
the critical bond-breaking step in the overall mechanism.  
Finally, ethanol exhibited a protective effect against the potent irreversible 
inhibitor 4-nitrobenzaldehyde, at high concentrations. At low concentrations of ethanol, 
however, ethanol appeared to enhance the inhibitory effects of the aldehyde. Recent 
literature has suggested that 4-nitrobenzaldehyde binds irreversibly to the heme group, 
creating an adduct that produces an inactive form of the enzyme (7). These studies appear 
to further support the notion that ethanol has a dramatic effect on the 2E1 metabolic 
profile. We have assessed the results of these experiments in relation to the broad scheme 
of P4502E1 catalysis. 
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I. A. Cytochrome P450 Role in Drug-Drug Interactions  
The Cytochrome P450 family is responsible for metabolizing a very large variety 
of substrates, including many of the drugs on the current market, as well as components 
of the human diet. Several cases of liver toxicity have been documented as a result of 
multiple xenobiotic compounds (that are metabolized by the same P450 isoform) being 
present at a given point in time. Whether through competitive or non-competitive 
mechanisms, complete inhibition or slight alterations of the normal catalytic pathway 
produces these toxic effects.  Two of the more commonly known drug interactions 
associated with P450 enzymes are grapefruit juice and Taxol® (3A4), and ethanol and 
acetaminophen (2E1) (9-14). Elucidating the mechanisms behind toxic effects that can 
arise from concurrent administration of certain substances is essential to ensure the 
efficacy and safety of treatment regimens.   
Taxol® is used primarily as an anti-cancer treatment, and is metabolized by the 
P4503A4 isoform. Studies have been done to investigate the role of grapefruit juice and its 
respective components as potential inhibitors of 3A4 (9-12). In vitro experiments have 
indicated that a class of compounds known as flavonoids (more specifically, 
furanocoumarins) may be responsible for the inhibitory effects, through enzyme 
inactivation (12). A reduction in the active form of 3A4 by these compounds resulted in 
increased systemic concentrations of Taxol®, stimulating a drug overdose type of 
response.  
The specific mechanism behind the effect of ethanol on 2E1-mediated 
acetaminophen metabolism has not been as straightforward. It is thought that ethanol 
! %!
“induces” the expression of the enzyme, due to the increased protein levels that have 
been documented upon ethanol treatment in rats (13, 14). This increase in 2E1 levels, and 
subsequently, an increase in the amount of acetaminophen metabolized via 2E1, is one 
possible explanation for acetaminophen toxicity when ethanol is present. Toxicity is 
thought to occur via the generation of highly reactive byproducts in the presence of 
ethanol, such as N-acetyl-p-quinolone imine (NAPQI), during acetaminophen breakdown 
(15, 16). Whether there is a single pathway by which damage occurs, or if multiple events 
contribute simultaneously, is still under great debate. It was postulated that when ethanol 
is present in the liver, it competes with acetaminophen for 2E1, but that the majority of 
the NAPQI is produced after ethanol has been cleared from the system (15). Due to an 
increase in the half-life of the 2E1 isoform after exposure to ethanol (from 7 hours to 37 
hours), as well as a decrease in enzyme degradation, the metabolism of acetaminophen is 
accelerated approximately 24 hours after ethanol consumption. Consequently, to 
rationalize the alterations in normal xenobiotic metabolism as a result of ethanol 
consumption, a more thorough understanding of the unique catalytic profile of 2E1, as 
well as the adaptive nature of ethanol oxidation is necessary. 
1. B. Cytochrome P4502E1 
 In recent studies, Cytochrome P4502E1 enzymes have been implicated in oxidative 
stress brought on by alcohol consumption and a number of other environmental factors 
by producing reactive oxygen species in the liver (2, 3). This enzyme may be responsible 
for generating hepatotoxic and carcinogenic intermediates in the course of metabolizing 
acetaminophen and N,N-dimethylnitrosamine (a constituent of cigarette smoke). Crystal 
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structures of the P4502E1 active site have recently been released, and have provided 
valuable information on the conformational features of the isoform (17). Figure I. 1 
shows the active site cavity, as well as a smaller distal cavity (gray mesh). 
 
 
Figure I. 1: Crystal structure of the P4502E1 active site, showing the active site (190 Å
3) 
and adjacent smaller cavity (77 Å3). (reproduced with permission from (17)) 
 
The 2E1 active site is one of the smallest of all the isoforms, which is consistent with the 
enzyme’s affinity for smaller substrates (18). The interior is also very hydrophobic in 
nature, so it is curious that ethanol is a substrate for the enzyme at all. The mere fact that 
2E1 plays a major role in the metabolism of such a polar molecule, despite the 
hydrophobicity of the active site environment, suggests that possible adaptations in 
catalysis may be in response to the increase in polarity.  
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Although 2E1 has the inherent ability to activate various substrates into highly 
reactive products, this is even more pronounced at elevated levels of ethanol 
concentration. Induction of the enzyme and the subsequent generation of reactive species 
have been connected with ethanol-induced liver injury (15). Our working hypothesis was 
that there is a connection between the induction and subsequent elevated expression of 
2E1 and the change in catalytic mechanism, to overcome the highly polar conditions of 
any one particular active site. Therefore, an attempt was made to establish experimental 
evidence regarding this adaptation in metabolism. The information from these studies 
may be valuable as a toxicological model for further in vivo studies, in an effort to reduce 
drug-drug interactions related to ethanol consumption and subsequent catalysis by the 
P4502E1 isoform. 
I. B. i.  Role of Effector Site in Catalysis 
 In the broader spectrum of P4502E1 catalysis, details concerning substrate 
specificity and oxidative mechanisms have been limited, and a lack of knowledge in 
theses areas has limited the overall potential of the enzyme as a therapeutic target. In light 
of this, studies were done by Collom et al. (2008) to discern the mechanism of substrate 
inhibition previously demonstrated by this isoform, though relatively unexplored (4). The 
studies suggest the existence of a site distal to the active site above the heme; an 
“effector” site that does not participate in catalysis, but instead has an allosteric effect on 
catalysis. This hypothesis was initially supported through steady state analysis with p-
nitrophenol, shown in Figure I. 2.  
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Figure I. 2: Michaelis Menten analysis of PNP oxidation in the presence of inhibitors 4-
methyl pyrazole (A) and indole (B), at increasing concentrations of each inhibitor. 
Kinetic parameters were calculated based on a single site competitive model (reproduced 
from with permission from (4)). 
 
The decrease in activity following the maximum velocity is not consistent with the 
traditional model for single substrate kinetics. Rather, it suggests that a second substrate 
binds to an effector site at higher concentrations, and inhibits catalysis within the active 
site. The significance of the effector site was further supported by the fact that despite an 
observed Vmax of 0.76 !M/min, traditional Michaelis-Menten calculations indicated that 
Vmax should have been 1.2 µM/min. Thus, only 64% of the maximum rate was actually 
reached, and it was concluded that certain catalytic properties are masked by the use of 
the traditional single substrate Michaelis-Menten kinetic model for the 2E1 isoform (4). 
!
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I. C. Influence of Ethanol on P4502E1 Catalytic Scheme 
 Studies regarding the role of the ethanol in oxidative stress and subsequent liver 
damage have been ongoing for several decades (1-3, 13-16). Multiple theories regarding 
the specific pathway by which ethanol causes oxidative damage have been proposed in 
the literature. Figure I. 3 shows two of the more widely accepted pathways.  
 
 
Figure I. 3: Role of Cytochrome P4502E1 in oxidative stress after ethanol treatment. 
 
It has been reported that ethanol consumption resulted in increased levels of P4502E1, 
leading to the assumption that ethanol somehow “induces” the isoform by up-regulation 
of protein expression (13). However, the results of these studies showed little or no 
increase in 2E1 mRNA levels, suggesting that the effect was not at the level of 
transcriptional activation. Instead, it was postulated that the increase in 2E1 levels was 
due to ethanol-mediated stabilization of the protein, and that this stabilization rendered 
the enzyme resistant to degradation (14).  
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 In addition to possible up-regulation of 2E1 expression, another potential 
explanation for ethanol-mediated toxicity is the generation of highly reactive species that 
have the capacity to alter other substrates. In particular, the 1-hydroxyethyl radical is 
assumed to activate acetaminophen into N-acetyl-p-benzoquinone imine (NAPQI), which 
contributes significantly to acetaminophen toxicity (15). Despite the amount of 
experimental evidence regarding the subsequent generation of reactive species, the 
catalytic details that lead to their production are not well understood (16). This may be 
due, in part, to the transient nature of the metabolic intermediates. Thus, in order to 
further characterize any possible interactions between ethanol and other substrates during 
metabolism, a more thorough profile of ethanol oxidation is necessary. 
I. C. i. Mechanism of 2E1-Mediated Ethanol Oxidation 
Previous mechanistic studies done by Guengerich et al. (19, 20) have indicated 
that the oxidation of ethanol proceeds through a “dual hydrogen abstraction pathway”, 
where abstraction from the alpha carbon was assumed to be the initial step, followed by 
oxygen rebound from the heme group to form a gem-diol intermediate, and then 
elimination of water to form the acetaldehyde product (Figure I. 4). A similar 
mechanism was proposed by Vaz et al. for the oxidation of benzyl alcohol to 
benzaldehyde by the 2E1 isoform (21). 
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Figure I. 4: Three proposed mechanisms for ethanol oxidation catalyzed by P4502E1 
(reproduced with permission from (22)). 
 
It was also suggested in the study that the active site was sterically unhindered for 
about 10 angstroms above the heme, allowing for several ethanol molecules to be present 
at any given time. This suggests that the active site may exist in conditions of both low 
and high polarity, and that polarity may cause a change in the catalytic scheme. Using 
energetic models, recent studies have proposed a new mechanism for oxidation in the 
presence of a highly polar active site, a “reverse dual hydrogen abstraction”, where 
abstraction occurs initially at the hydroxyl group, with no oxygen rebound, in order to 
counteract increasing polarity in an environment that is very hydrophobic in nature (22).  
  
 
 
 
!
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Energy profiles were calculated for conditions of varying polarity, to determine 
the favored pathway in each case. Figures I. 5 and I. 6 illustrate the energy profiles from 
the gem-diol and reverse dual hydrogen abstraction mechanisms, respectively, for both 
low and high active site polarity conditions.  
 
 
 
Figure I. 5: Energy profile for ethanol oxidation via gem diol formation. Gas phase (no 
parentheses), weak polar medium (parentheses), and polar medium (square brackets) 
energies are shown (reproduced with permission from (22)). 
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Figure I. 6: Energy profile for ethanol oxidation via reverse dual hydrogen abstraction 
mechanism. Gas phase (no parentheses), weak polar medium (parentheses), and polar 
medium (square brackets) energies are shown (reproduced with permission from (22)). 
 
A rate-limiting step of hydrogen abstraction from the alpha carbon is assumed for 
the gem-diol mechanism, and Figure I. 5 shows that the energy barrier for this step 
increases when corrections are done for both low and high polarity environments. By 
contrast, hydrogen abstraction from the hydroxyl group is assumed to be the rate-limiting 
step for the reverse dual hydrogen abstraction pathway, and as Figure I. 6 illustrates, a 
decrease in the energy barrier for this step is seen for each environmental case. In 
summary, initial gas phase calculations result in a 2.0 kcal/mol lower energy barrier for 
the gem-diol mechanism, however, corrections for each polar environment raise this 
barrier to 1.3 kcal/mol higher than the proposed reverse dual hydrogen abstraction 
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mechanism. These observations have lead to the conclusion that the switch in metabolic 
pathway can explain the adaptive response of P4502E1 to high blood ethanol 
concentration, which results in an acceleration of metabolism. 
I. C. ii.  Metabolic Adaption to Increasing Active Site Polarity 
Studies previously done by Raner et al. (7) evaluated possible intermediates 
formed during P4502E1 oxidation of aldehyde substrates. The traditional pathway for P450 
proceeds through an intermediate known as Compound I, an iron-oxo intermediate that 
initiates nucleophilic attack on the substrate. However, through an examination of the 
inactivation of P450 by aldehydes, an alternate pathway through a peroxo-iron 
intermediate has been proposed. The inactivation of the enzyme occurs when a radical 
species, produced as the peroxo- intermediate decomposes, reacts with the heme to form 
an adduct (Figure I. 7).  
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Figure I. 7: Proposed pathways for P450-mediated conversion of aldehyde substrates to 
carboxylic acid, olefin and alcohol products. (reproduced with permission from (7)) 
 
 
Catalysis resulted in the formation of two distinct products from the oxidation of 
the aldehyde substrate. The first product, formed through the traditional pathway 
involving Compound I, was the corresponding carboxylic acid. The second product was 
an n-1 alcohol that could be quantified by HPLC. This product is thought to form via a 
peroxo pathway within the P450 catalytic cycle. The results from this study further 
support the notion that P450 enzymes may have multiple pathways for the metabolism of 
a given substrate. Regarding the current study, it is uncertain whether a change in active 
site polarity would influence the partitioning between these pathways; however, it is 
reasonable to expect that it would. 
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Since impairment of the catalytic competence of P450 by
aldehydes requires metabolic activation, we have considered
the possible relevan e of the two known metabolic pathways
for aldehyde metabolism by this cytochrome, namely,
oxidative carbon-carbon bond cleavage to produce formate
and the n-1 product (Vaz et al., 1994) and oxidative
conversion to the carboxylic acid (Watanabe et al., 1991).
The former pathway has been examined extensively as it
relates to the desaturation reaction catalyzed by the ste-
roidogenic P450s, aromatase (Oh & Robinson, 1993), and
P45017R (Swinney & Mak, 1994). Akhtar et al. (1982) first
proposed that the deformylation reaction occurs via the
nucleophilic attack of an iron-bound peroxide on the carbonyl
carbon of the aldehyde, resulting in the formation of a
peroxyhemiacetal intermediate, which undergoes homolytic
O-O bond cleavage and rearranges to give the observed
products. In an attempt to provide evidence for peroxo-
iron in this reaction, Vaz et al. (1996) made a mutant of
P450 2B4 in which t e conserved Thr-302 was converted
to Ala, thus eliminating the putative proton donor for
promotion of the heterolytic O-O bond cleavage step. This
mutant was 5-10 times as active as he wild-type enzyme
in converting cyclohexanecarboxaldehyde to cyclohexene,
while the ability of the mutant to catalyze benzphetamine
N-demethylation and cyclohexane hydroxylation was se-
verely diminished. In the present study we have used this
T302A mutant to examine the possibility that peroxo-iron
may be involved in the inactivation of P450 by aldehydes.
The results show that the mutant is inactivated by trans-
cinnamaldehyde about 4 times faster than the wild type. As
with full-length wild-type 2B4, heme loss with the T302A
mutant correlates very well with the rate of inactivation.
Thus, our results with the mutant enzyme show an apparent
role of the deformylation pathway in activity loss and heme
destruction.
Watanabe et al. (1992) have examined carboxylic acid
formation in microsomes from a number of xenobiotic
aldehydes and have made the interesting observation that
18O from molecular oxygen is incorporated into this product
from saturated, but not unsaturated, aldehydes. They suggest
either the involvement of two distinct enzyme systems
(aldehyde dehydrog nases and P450s) or alter ative catalytic
mechanisms for the same enzyme system. In the present
study we have examined the acid-forming reaction with
purified P450 2B4 in a reconstituted enzyme system and have
found that, in general, the rate of formation of carboxylic
acids from aldehydes greatly exceeds that for the formation
of the n-1 products. For example, with 1.0 mM 2-phenyl-
propionaldehyde as a substrate for the full-length 2B4, acid
formation is favored nearly 50:1 (data not presented).
Furthermore, inactivation of the T302A mutant enzyme by
cinnamaldehyde is much more rapid than that of the wild-
type enzyme but that cinnamic acid formation by the mutant
is nearly abolished.
In an attempt to establish a correlation between product
formation and inactivation, we have measured the rates of
acid formation, alcohol formation, and P450 inactivation with
the primary and secondary aldehydes 3- and 2-phenylpro-
pionaldehyde. At saturating levels of the two compounds,
the rate of inactivation of P450 2B4 by the 3-phenyl
compound was much higher than with 2-phenylpropional-
dehyde. Under identical conditions, the rate of acid forma-
tion from the secondary aldehyde was higher than for the
primary aldehyde. Alcohol formation, however, was much
more rapid with 3-phenylpropionaldehyde. Of further inter-
est, the 2B4 T302A mutant that serves as a marker for peroxo
Vs oxenoid chemistry is dramatically enhanced in its ability
to effect the formation of the n-1 alcohol from 2-phenyl-
propionaldehyde, while the ability to promote acid formation
is nearly lost. The data suggest that the mechanism of P450
inactivation by aldehydes is related to n-1 alcohol formation
and distinct from carboxylic acid formation.
Additional evidence concerning these reactions was ob-
tained with several aldehydes labeled with a deuterium atom
at the aldehyde carbon. A Vmax isotope effect of 2.6 on acid
formation was observed, in keeping with a mechanism
involving a partially rate-limiting hydrogen abstraction
followed by oxygen rebound; thus, an oxenoid-iron inter-
FIGURE 5: Proposed pathways for the P450-dependent conversion of a typical aldehyde to the carboxylic acid with involvement of the
oxenoid-iron species or to the n-1 olefin and alcohol with involvement of the peroxo-iron species. Fe represents the iron atom at the
active site. Also shown is the role of the alkyl radical generated in the deformylation pathway in heme adduct formation, which apparently
leads to P450 inactivation.
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In order to consider possible causes for adaptations in catalysis, certain details 
regarding the active site structure should be noted. Figure I. 8 gives an overhead view of 
the substrate access channel, the catalytic site, and the effector site of P4502E1.   
 
 
Figure I. 8: Overhead depiction of the P4502E1 active site. Substrate access channel is 
indicated by the directional arrow. (Reproduced with permission from (17)) 
 
 
Two phenylalanine residues separate the catalytic and effector sites, which re-
emphasizes the hydrophobic nature of the environment. It may be reasonable to conclude, 
therefore, that the presence of ethanol in high concentrations initiates the rotation of those 
two residues (in order to minimize unfavorable interactions) and subsequently “opens the 
gate” to the distal effector site. This change in conformation would theoretically allow for 
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greater substrate flexibility, which may lead to changes in bond cleavage and the 
formation of atypical products. Therefore, with the assumption that 2E1 is capable of 
adapting its metabolic profile under conditions of varying polarity, the objective of these 
studies was to characterize any interactions between ethanol and several different 
substrates. Because the active site is very hydrophobic in nature, an increased 
concentration of ethanol may lead to alterations in the metabolism of other substrates of 
this isoform. The implications of this research may also be applied to other Cytochrome 
P450 isoforms, as most P450 active sites are hydrophobic and, therefore, may also be 
capable of adapting their catalytic schemes under the stress of very polar conditions.  
With this in mind, our ultimate goal is not only to characterize this unique metabolic 
phenomenon in the 2E1 isoform, but also to expand and apply these results to the broader 
scheme of the Cytochrome P450 enzymatic profile.
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CHAPTER II 
 
EXPERIMENTAL METHODS 
 
II. A. Para-nitrophenol Substrate Inhibition Assays 
 Rabbit liver microsomes served as a source of P4502E1, and stock solutions of 1 
mM PNP and 10% ethanol (v/v) were used for each analysis. Typical reaction mixtures 
contained 5 !L of microsomes, 50-700 !M PNP, 34 or 51 mM ethanol, and NADPH-
regenerating system (2 microunits/!L glucose-6-phosphate dehydrogenase, 10 mM 
glucose-6-phosphate, 1.0 M potassium phosphate buffer {pH 7.4} containing 33 mM 
MgCl2, and 500 !M NADP+) in a final reaction volume of 500 !L. Reaction mixtures 
were initiated upon addition of NADPH regenerating system, and incubated at 37oC 
for 30 minutes. Reactions were quenched with 200 !L of 6% perchloric acid, placed on 
ice for 10 minutes, and centrifuged for 10 minutes at 3500 rpm. The supernatant was 
extracted for analysis by HPLC. The reaction catalyzed by 2E1 is shown in Figure II. 1, 
where quantification of the p-nitrocatechol product by peak integration was used to 
determine reaction velocity. A standard curve was generated using stock solutions of pure 
p-nitrocatechol (5-25 µM), where peak integration was plotted as a function of 
concentration (Figure II. 2). The resulting linear regression was used to determine the 
concentration of product formed in each reaction. Reaction velocity (in µM PNC formed 
! ")!
per minute) was subsequently calculated by dividing the total amount of product formed 
by the assay duration time of 30 minutes.  
 
 
Figure II. 1: Representative HPLC chromatogram of P4502E1-mediated conversion of p-
nitrophenol (Rt 240 seconds) to p-nitrocatechol (Rt 100 seconds). 
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Figure II. 2: Standard curve of HPLC peak integration versus p-nitrocatechol (PNC) 
concentration for conversion of peak area to reaction velocity in studies where p-
nitrophenol was the probe substrate. Reaction velocities were calculated by dividing the 
total amount of PNC by 30 minutes (total reaction run time), to give units of µM PNC 
formed per minute. Standard solution concentrations ranged from 5-25 µM PNC. HPLC 
conditions were identical to those used in PNP assays.  
 
II. A. i. HPLC Analysis and Determination of Michaelis-Menten Constants. 
 Product formation was quantified by HPLC, (Shimadzu LC-20AT/ Prominence 
Liquid Chromatography system) using a SPC-20A/ Prominence UV/Vis Detector at a 
wavelength of 340 nm. Samples were injected in 40 µL aliquots onto an Agilent C8 
reverse phase column, with a mobile phase consisting of 25% acetonitrile and 74.5% 
water (acetic acid present at 0.5% in both solutions). The flow rate was set to 0.600 
mL/minute, with a total run time of 5 minutes per sample. Reaction velocity was plotted 
as a function of substrate concentration, and kinetic constants were determined using 
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nonlinear regression analysis (GraphPad Prism, GraphPad Software, Inc.). The Michaelis 
Menten equation was used to determine the Km and Vmax values for the control reaction 
(Equation. II. 1). 
 
 
Equation II. 1. 
 
For reactions containing ethanol as an inhibitor (at increasing concentrations), Kmapp  and 
Ki were all determined using the following equation:  
 
Kmapp = Km * (1 + [I]/Ki) 
Equation II. 2. 
The concentration of the ethanol inhibitor is represented by [I], and Kmapp is the observed 
Km value upon the addition of inhibitor to the reaction mixture. 
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II. B. Deuterium Isotope Studies. 
Reaction conditions were identical to the PNP studies except for the following: 
PNP was replaced with 1.5 µmol [1-2H1]-benzyl alcohol (purified by HPLC), and 0, 17, 
34, or 51 mM ethanol. After incubation, equal volumes of CH2Cl2 were added to quench 
each reaction, and the CH2Cl2 extract was analyzed by GC-MS. GC-MS temperature 
program conditions were 70oC for 2 min, followed by 8oC/min increase to a final 
temperature of 250oC, which was held for 5 min. Under these conditions, the 
benzaldehyde product eluted at 6.3 minutes. Peak ratios at 106 m/z and 107 m/z, 
corresponding to benzaldehyde and [2H]-benzaldehyde, respectively, were used to 
determine the intrinsic isotope effect. 
II. B. i. Synthesis and Purification of 1-[
2
H1]-Benzyl Alcohol 
 Synthesis protocol was adapted from the procedure used by Vaz et al. (21). A 25 
mL reaction mixture of 5.0 M benzaldehyde in 20% ethanol and 250 mmol of sodium 
borodeuteride (98% isotopic purity, Aldrich) was stirred overnight at room temperature. 
The solution was subsequently diluted with 25 mL of water, and extracted twice with 10 
mL portions of CH2Cl2. The desired product was isolated by fractionation with HPLC 
(Figures II. 3 and II. 4).  
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Figure II. 3: HPLC chromatogram of benzaldehyde (Rt 2.7 min) and 1-[
2H1]-benzyl 
alcohol product (Rt 2.1 min), from synthetic reaction mixture. Separation was achieved 
by injecting 100 µL of sample onto an Agilent C8 column (4.6 x 150 mm), with a mobile 
phase of consisting of 60% acetonitrile, 39.5% H2O, 0.5% acetic acid. Flow rate was 1 
mL/min, and the total run time was 5 minutes. Absorbance detection was set to 254 nm. 
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Figure II. 4: HPLC chromatogram of fraction containing 1-[2H1]-benzyl alcohol product 
purified from initial synthetic reaction mixture. HPLC conditions were identical to those 
used for the reaction mixture.!
 
 
II. B. ii. GC-MS Analysis of Purified 1-[
2
H1]-Benzyl Alcohol 
 
After HPLC purification from the synthetic reaction mixture, incorporation of 
deuterium into the benzyl alcohol product was confirmed by GC-MS (m/z peak 109), as 
shown in Figure II. 5.  The purity of the product was assessed by comparing the peak 
intensity of the deuterated form of the alcohol to the undeuterated form (m/z peak 108).  
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Figure II. 5: Mass spectrum of purified 1-[2H1]-benzyl alcohol. GC-MS temperature 
program conditions were 70oC for 2 min, followed by 8oC/min increase to a final 
temperature of 250oC, which was held for 5 min. A volume of 1 µL was injected via split 
less injection, and the injection and ion source temperatures were set to 250oC. Under 
these conditions, benzyl alcohol eluted with a retention time of 7.6 minutes. The presence 
of 1-[2H1]-benzyl alcohol was confirmed by a peak at 109 m/z, corresponding to the 
mono-deuterated form of benzyl alcohol (108 m/z).  
 
 
 The peak intensity of the deuterated product was approximately double that of the 
undeuterated form. However, the calculation of a true intrinsic isotope effect is dependent 
upon the use of a highly pure solution of deuterated compound, to ensure that any change 
in label incorporation within the product is truly the result of a change in bond cleavage. 
Therefore, interpretation of the preference for bond cleavage, as determined by 
incorporation of the deuterium label into the aldehyde product, would be dramatically 
altered by the presence of the undeuterated alcohol in the reaction mixture. In light of 
this, calculated intrinsic isotope effect values from our studies were solely used to 
analyze a general shift in label incorporation, rather than true intrinsic isotope effects.  
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II. C. 4-Nitrobenzaldehyde Reversibility Studies  
 The reversibility assay was used to evaluate whether ethanol could disrupt the 4-
nitrobenzaldehyde-mediated inactivation of P4502E1. By incubating the enzyme mixtures 
under different experimental conditions prior to the addition of the probe substrate, it was 
possible to draw conclusions about the mode of interaction between ethanol and 4-
nitrobenzaldehyde.  
II. C. i. Reversibility Assay Protocol 
Four separate enzyme samples were prepared side-by-side, each with a total 
volume of 100 µL. A schematic of the experimental setup for each sample is shown in 
Figure II. 6. Following a pre-incubation for 15 min at 37 oC, the activity of P4502E1 was 
assayed by diluting each sample 1:20 in final reaction mixtures containing 1.0 mM 
NADPH, 50 µM p-nitrophenol and 100 mM phosphate buffer (pH 7.4), and subsequently 
assayed as described previously in PNP substrate inhibition studies.  Each experiment 
was carried out in duplicate.  
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Figure II. 6: Experimental setup for 4-nitrobenzaldehyde reversibility assays. Each pre-
incubation mixture contained 50 µL of a 100 mM phosphate buffer (pH 7.4) solution, 20 
µL of rabbit liver microsomes, 5 µL of a 10 mM NADPH solution, and the specified 
substrates. Fifteen microliters of a saturated solution of 4-nitrobenzahyde was added to 
samples labeled +NBA. Reaction samples labeled +Ethanol contained 17, 34, or 51 mM 
ethanol. Following pre-incubation, 25 µL was added to each of the activity assay 
mixtures (carried out in duplicate). Each activity assay mixture contained 100 mM 
phosphate buffer (pH 7.4), 1.0 mM NADPH, and 50 µM p-nitrophenol (probe substrate).  
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CHAPTER III 
 
RESULTS AND DISCUSSION 
 
 
III. A. PNP Substrate Inhibition Studies 
In order to assess the nature of a recently proposed “effector” site that exists distal 
to the heme active site, the present study was employed to investigate the role of the site 
in the substrate inhibition pattern observed in PNP oxidation, and the influence of ethanol 
on this phenomenon. Figure III. 1 is an illustration of the potential ligand-ligand 
interactions between the two sites.  
 
 
 
Figure III. 1: Surface depiction of catalytic and effector binding sites for P4502E1 
(reproduced with permission from (4)).  
! #)!
Interactions between molecules occupying the catalytic and effector sites may have the 
potential to alter catalysis, either through the generation of unexpected products, or by 
altering the rate-limiting step in reactions. In light of the proposed rate-limiting step of 
product release in ethanol oxidation (19, 20), it may be reasonable to conclude that 
interactions between p-nitrophenol molecules occupying both sites slows the process of 
product formation and release, which results in the observed decrease in activity at high 
concentrations of substrate. 
Because the substrate inhibition phenomenon is observed at higher PNP 
concentrations, it was postulated that this was the result of PNP molecules binding to an 
effector site and inhibiting catalysis. In the current study, ethanol was added to the 
reaction mixture at increasing concentrations to observe any influence on PNP oxidation 
kinetics. Our hypothesis is that the capacity of ethanol to influence PNP substrate 
inhibition, by disrupting interactions between sites, should result in a loss of substrate 
inhibition. If a shift is observed, it may be postulated that ethanol competes with 
subsequent PNP molecules for binding to the active site, resulting in the change in the 
observed substrate inhibition pattern. Thus, in vitro evidence concerning the site’s 
apparent role in catalysis was ascertained through analysis of kinetic constants. 
III. A. i. Michaelis-Menten Analysis  
As illustrated in Figure III. 2, a decrease in activity for the control (containing 
only PNP) was seen at concentrations of 150 !M and above, which agrees with recent 
studies by Collom et al. (4) where, in the absence of inhibitor, a decrease in activity 
above 100 !M PNP was also observed (Figure I. 2), and such observations were 
! #*!
reproduced in the current study. Figure III. 3 shows the results from steady state 
oxidation assays in control reactions. Also included are the reaction velocities beyond a 
substrate concentration of 150 µM (truncated from experimental data, as calculated via 
nonlinear regression, GraphPad Prism) to provide a fit to the traditional Michaelis-
Menten kinetic model, where saturation of the enzyme at or around the maximum 
velocity of the reaction is demonstrated by a plateau in the curve. This allowed for 
comparison between expected Michaelis-Menten behavior and the apparent substrate 
inhibition phenomenon demonstrated previously in the literature (4), as well as in the 
present study. 
 Based on the Michaelis-Menten model calculations, the velocity for the control 
reaction should have reached a maximum of approximately 0.179 µM/minute. However, 
at a substrate concentration of 150 µM, the velocity only reached 0.149 µM/minute 
before a decrease was observed. Thus, only 83% of the Vmax predicted by the traditional 
Michaelis Menten kinetic model was actually reached. The difference between constants 
calculated from traditional single-site kinetic models and those determined 
experimentally indicated that a more complicated kinetic model may be necessary to 
accurately analyze the 2E1 catalytic scheme. A similar conclusion was reached in the 
prior studies done by Collom et al. (4), where only 64% of the predicted maximum 
velocity was observed. Such conclusions have prompted further characterization of the 
substrate inhibition phenomenon using inhibitors, to characterize the unique kinetic 
profile of the 2E1 isoform. More specifically, the role of the proposed “effector site” in 
the observed decline in activity at higher substrate concentrations was assessed.  
! $+!
 
 
Figure III. 2:  Plot of reaction velocity versus substrate concentration, for the oxidation 
of p-nitrophenol to p-nitrocatechol by P4502E1. Michaelis Menten Model data (red) is 
truncated from experimental data (blue) at 150 µM PNP, and the remaining velocities 
calculated using GraphPad Prism (nonlinear regression, Michaelis-Menten equation) to 
provide a basis for comparison between trends in experimental velocities and typical 
Michaelis-Menten kinetic behavior. Reaction velocities for the control data were 
calculated from p-nitrocatechol peak integration, detected at 340 nm, using the standard 
curve shown in Figure II. 2. 
 
III. A. ii. Effect of Ethanol on PNP Substrate Inhibition 
 To probe further details regarding the role of the proposed effector site in the 2E1 
catalytic profile, as well as the effect of ethanol on the kinetic behavior of the isoform, 
varying concentrations of ethanol were added to the reaction mixture. The results of 
assays containing 34 mM and 51 mM ethanol are shown in Figure III. 3. 
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Figure III. 3:  Plot of reaction velocity versus substrate concentration, for the oxidation 
of p-nitrophenol to p-nitrocatechol by P4502E1, for reactions containing no inhibitor, 34 
mM ethanol (A) or 51 mM ethanol (B). Reaction velocity was calculated from p-
nitrocatechol peak integrations, detected at 340 nm, using the standard curve in Figure 
II. 2. 
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Upon the addition of ethanol, the oxidation of p-nitrophenol appeared to 
demonstrate more Michaelis-Menten like behavior, showing saturation rather than a 
substrate inhibition pattern. Interestingly, the maximum velocity for reactions containing 
ethanol did not approach the Vmax of 0.179 µM/minute predicted by the Michaelis-
Menten model for the control; rather, they appeared to approach the plateau seen after the 
observed decrease in activity, at a reaction velocity of approximately 0.080 µM/minute. 
We concluded that this plateau represented the saturation of the effector site by PNP in 
the control reaction, based on the assumption that product release was rate-limiting in the 
overall reaction. This conclusion was further supported by the observed kinetic trends 
after ethanol was added to the reaction mixture, where the maximum velocity appeared to 
converge at approximately the same value. In order to provide a more substantial basis 
for this conclusion, it was necessary to assess the mode of action by which ethanol 
interfered with catalysis. 
To determine the mode of inhibition, the apparent Vmax and Km values calculated 
from reactions containing ethanol were compared to those calculated for the Michaelis-
Menten model curve (Table III. 1). Comparison with the model data allowed for more 
straightforward analysis of the influence of ethanol in determining a potential mechanism 
for inhibition, given that a definitive two-site substrate inhibition model to fit this 
particular case has not yet been established (23). 
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Table III. 1: Summary of kinetic constants from PNP Substrate Inhibition studies. 
 Km (µM) Vmax (µM/min) Kmapp Vmaxapp 
Michaelis Menten Model 34 0.179 N/A N/A 
Experimental Control 29 0.149 N/A N/A 
34 mM Ethanol N/A N/A 40 0.079 
51 mM Ethanol N/A N/A 64 0.082 
 
Comparison of the control and apparent maximum velocities, as well as the 
enzyme’s affinity for PNP (represented by Km values, which indicate the substrate 
concentration needed to reach half the maximal velocity) formed the basis for assessing 
mode of inhibition demonstrated by ethanol (24). Upon adding 34 mM and 51 mM 
ethanol, the apparent Km values were 40 µM and 64 µM, respectively, and the increase in 
value was an indication that ethanol was competing with PNP for binding at the active 
site. In general, an increase in Km when a potential inhibitor is added to the reaction 
mixture suggests that a higher concentration of the substrate is necessary to reach the 
maximum velocity of the reaction (24). A change in the Vmax value was also observed 
when ethanol was present, where reactions containing ethanol appeared to converge at a 
maximum of approximately 0.080 µM PNC formed per minute. The difference between 
the observed value from the Michaelis-Menten model and control reactions, and those 
containing ethanol suggests that ethanol also interferes with a particular step in catalysis. 
In light of the fact that the addition of ethanol resulted in a change in both Km and Vmax 
values, we concluded that the mode of inhibition was mixed in nature, where ethanol 
potentially demonstrated the capacity to interfere with substrate binding and catalytic 
! $%!
conversion to product. More specifically, we concluded that ethanol inhibits the binding 
of PNP to the active site in a competitive nature (based on the increase in Km), but also 
has an effect on the rate-limiting step of product release (as indicated by the difference in 
maximum velocity). The existence of the effector site, and its potential role in this 
scheme was ultimately supported by the mixed mode of inhibition by ethanol in these 
studies and the fact that the maximum velocity of the reactions containing inhibitor 
converged at the same value observed in control reactions when saturation of the second 
site occurred.  
III. B. Isotope Effect Studies with 1-[2H1]-Benzyl Alcohol 
 Similar to the mechanism proposed by Wang et al. (21) for ethanol oxidation, the 
oxidation benzyl alcohol by P4502E1 is traditionally assumed to proceed through a dual 
hydrogen abstraction pathway, where abstraction from the alpha carbon was found to be 
partially rate-limiting. In the reverse dual-hydrogen abstraction pathway, hydrogen 
abstraction from the hydroxyl group would be rate-limiting, and the change the in rate-
limiting step may occur as a result of increasing polarity in the 2E1 active site (22). In 
light of this, we attempted to evaluate the effect of ethanol, and the subsequent change in 
active site polarity on the partitioning between pathways and alterations in the rate-
limiting step in catalysis. 
In the current study, experiments probing the effect of ethanol on the intrinsic 
isotope effect of benzyl alcohol appeared to provide support regarding the influence of 
ethanol on a wide range of 2E1 metabolic schemes. Deuteration at a single position on 
carbon one of benzyl alcohol would traditionally allow for evaluation of a particular 
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bond-breaking step critical to catalysis. The method is based on the idea that differences 
in the vibrational energy of a C-H versus a C-D bond vary due to a significant mass 
difference between the hydrogen and deuterium atoms (24, 25). The vibrational energy of 
the C-D is much lower due to the increase in mass of deuterium, which results in greater 
difficulty breaking that particular bond. Such a scenario manifests itself by decreasing the 
observed reaction rate with respect to the rate seen when a hydrogen is abstracted (24-
26). By comparing the two experimental reaction rates, the importance of the bond in 
question in the context of the overall reaction can be evaluated (27).  
The possible mechanistic routes are shown in Figure III. 4, where the 
conventional intrinsic isotope effect is calculated based on the ratio of peaks at the m/z 
value for both possible products. However, the purity of the benzyl alcohol substrate 
limited our ability to determine absolute isotope effects. As a result, signal intensities for 
the deuterated and undeuterated product formed in each experiment was used to observe 
a general shift in the preference for bond cleavage, not for the determination of true 
isotope effects. The results for control reactions, and reactions containing 17, 34, or 51 
mM ethanol are shown in Figures III. 5 -III. 8. 
 
 
! $'!
 
Figure III. 4: P4502E1 oxidation of 1-[
2H1]-benzyl alcohol. 
 
 
 
Figure III. 5: GC-MS fragmentation pattern for benzaldehyde formed from 1-[2H1]-
benzyl alcohol in the control reaction (containing no ethanol). GC-MS conditions were 
identical to those used in the purification of  1-[2H1]-benzyl alcohol. 
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Figure III. 6: GC-MS fragmentation pattern for benzaldehyde formed from 1-[2H1]-
benzyl alcohol in the reaction containing 17 mM ethanol. GC-MS conditions were 
identical to those used in the purification of 1-[2H1]-benzyl alcohol. 
 
 
 
Figure III. 7: GC-MS fragmentation pattern for benzaldehyde formed from 1-[2H1]- 
benzyl alcohol in the reaction containing 34 mM ethanol. GC-MS conditions were 
identical to those used in the purification of 1-[2H1]-benzyl alcohol. 
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Figure III. 8: GC-MS fragmentation pattern for benzaldehyde formed from 1-[2H1]-
benzyl alcohol in the reaction containing 51 mM ethanol. GC-MS conditions were 
identical to those used in the purification of  1-[2H1]-benzyl alcohol. 
 
III. B. i. Determination of Intrinsic Isotope Effect  
Assuming that pure deuterated benzyl alcohol was used, the intrinsic isotope 
effect could be quantified by the ratio of product m/z peak intensities, which serves to 
represent the rate of deuterated versus non-deuterated product formation, and was 
calculated according to Equation III.1: 
  Equation. III.1. 
 
Due to the lack of pure substrate, theoretical isotope effect values were calculated to 
observe any overall shift in bond cleavage upon the addition of ethanol. The dominating 
peak in each case (106 m/z) represented the un-deuterated product, with a small 
percentage of products retaining the deuterium label. Table III. 2 lists the GC-MS signal 
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intensities and theoretical kD values for each experimental condition, as determined 
through analysis of the GC-MS chromatograms in Figures III. 5 – III. 8. 
 
Table III. 2: Signal intensities for conversion of 1-[2H1]-benzyl alcohol to benzaldehyde 
or 2H-benzaldehyde, at different concentrations of ethanol. 
 
 
 
Control 
17 mM 
Ethanol 
34 mM 
Ethanol 
51 mM 
Ethanol 
Signal Intensity (107 m/z) 120,677 42,490 25,880 15,207 
Signal Intensity (106 m/z) 1,531,000 540,123 240,400 110,670 
KH/KD 0.0788 0.0786 0.108 0.137 
 
 
The magnitude of the intrinsic isotope effect values appeared to suggest that 
cleavage of the deuterium label was more favorable than hydrogen abstraction, despite 
the lower vibrational energy associated with the increase in mass. It was concluded that 
the use of impure substrate was responsible for the observed isotope effect values. Even 
so, the apparent increase in isotope effect magnitude for reactions containing higher 
concentrations of ethanol indicated that there may still be some influence exerted on the 
preferred metabolic pathway. The rate of the undeuterated product formation was 
significantly higher than that of deuterated product formation in the control, as well as 
reactions containing 17 mM ethanol. The change in label incorporation was observed 
beyond an ethanol concentration of 17 mM, which is below the reported Km of 20 mM 
for this substrate (19, 20). At concentrations above the reported Km value, the amount of 
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deuterated product formed began to decrease, indicating that an “unmasking” of the 
isotope effect may be taking place, where hydrogen abstraction was more efficient than 
deuterium abstraction in the presence of ethanol.  
III. C. 4-Nitrobenzaldehyde Reversibility Studies 
 In order to further evaluate the potential influence of ethanol on P4502E1 
mechanism, the ability of ethanol to interfere with the inactivation of rabbit Cytochrome 
P450s by the aldehyde substrate was probed in these experiments. Figure III. 9 shows 
the amount of product formed of these experiments for control reactions, reactions 
containing 4-nitrobenzaldehyde or ethanol, and those containing both compounds (where 
the conversion of p-nitrophenol to p-nitrocatechol was used to determine the level of 2E1 
activity). The activity of 2E1 was significantly reduced upon the addition of 4-
nitrobenzaldehyde to the reaction mixture, and was reduced to a lesser degree when 
ethanol was added.  
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Figure III. 9: Plot of P4502E1 activity in control reactions, and in the presence of 4- 
nitrobenzaldehyde, ethanol, or both. The concentration of ethanol was varied to evaluate 
the effect on activity, as measured by the conversion of p-nitrophenol to p-nitrocatechol.  
 
This is consistent with the idea that both compounds can act as inhibitors, but 4-
nitrobenzaldehyde is much more potent, as it has been documented as one of the most 
potent irreversible inhibitors of the 2B4 isoform (7). Also shown in Figure III. 10, the 
percent activity of the enzyme increased when incubated with higher concentrations of 
ethanol and 4-nitrobenzaldehyde, relative to reactions containing only the aldehyde. The 
degree of increase was dependent on the amount of ethanol present, where the activity 
was even further restored as the concentration of ethanol increased. 
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Figure III. 10:  Plot of percent activity of P4502E1, as measured by the conversion of p-
nitrophenol to p-nitrocatechol, in the presence of 4-nitrobenzyaldehyde (saturated) and17 
mM, 34 mM or 51 mM ethanol. 
 
At the lowest concentration of ethanol, the inhibitory effects appear to be additive, 
as the activity when both compounds are present was lower than when either compound 
was present independently. However, as the concentration of ethanol increased, the 
activity when both compounds were present was greater than what was observed 
independently, indicating that ethanol may have been exhibiting a pseudo-protective 
effect at this stage. Because 4-nitrobenzaldehyde may be an irreversible inhibitor of this 
isoform, it may be postulated that the restoration of activity in the presence of higher 
concentrations of ethanol may also be connected to the increased polarity of the active 
site. 
To rationalize the conclusion that active site polarity also played a role in the 
protective effect of ethanol observed in these studies, the results of these studies were 
evaluated in the context of the conventional mechanism of P450 inactivation by aldehyde 
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substrates, as proposed by Raner et al. (7). The mechanism is shown in Figure III. 11, 
where the peroxo intermediate at the active site attacks the aldehyde via nucleophilic 
attack, creating a free radical that eventually covalently attacks the enzyme and renders it 
inactive. The synergistic effect that was observed in reactions containing 17 mM ethanol 
seems to suggest that the formation of the peroxo intermediate and subsequent 
inactivation is favored under conditions of low active site polarity. The restored activity 
that was observed in reactions containing 34 and 51 mM ethanol was also rationalized 
mechanistically. As shown in Figure I. 7, proton donation is required for the conversion 
of the peroxo to the iron-oxo heme intermediate, and this results in the formation of the 
carboxylic acid by the active form of the enzyme. Based on the assumption that as active 
site polarity increases, the amount of available proton donors also increases, we proposed 
that a shift in the intermediate formed during catalysis may be responsible for the 
restoration in activity. This notion was supported in these studies, where activity of the 
enzyme increased as the ethanol concentration increased. Because the protective effect 
was observed at higher concentrations of ethanol, and consequently, increased active site 
polarity, it was concluded that ethanol may cause a shift in the partitioning of the 
inactivation pathway, through a change in the particular heme intermediate formed during 
metabolism.  
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Figure III. 11: Proposed mechanism for inactivation of P4502E1 by aldehydes, through 
adduct formation at the meso- position of the heme group.
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CHAPTER IV 
CONCLUSIONS 
 
 
 Ethanol has demonstrated the ability to influence a number of Cytochrome 
P4502E1 catalytic schemes. The previously documented event of substrate inhibition that 
occurs with p-nitrophenol was thought to occur as a result of ligand-ligand interactions 
between one substrate bound at the active site, and another in a distal cavity described as 
an “effector site” (4). A decrease in activity was observed at higher concentrations of 
PNP, but the addition of ethanol restored the kinetic profile to Michaelis-Menten model 
behavior. Acting through mixed type inhibition, it was assumed that ethanol disrupted the 
interaction of PNP molecules between the catalytic and effector sites.  
 Given the fact that the active site of the 2E1 isoform is very hydrophobic, the 
addition of a polar molecule causes a great deal of stress. In the case of these studies, the 
stress of increasing polarity caused a dramatic change in the metabolic scheme of benzyl 
alcohol and 4-nitrobenzaldehyde. Although the purity of the deuterated benzyl alcohol 
substrate limited our ability to analyze true isotope effects, we were able to observe an 
“unmasking” of the isotope effect when ethanol was added to the reaction mixture. More 
specifically, it appeared that as the concentration of ethanol increased, hydrogen 
abstraction became more favorable. Furthermore, the ability of ethanol to influence the 
partitioning of the 4-nitrobenzaldehyde pathway, potentially through a shift in heme 
! %'!
intermediate formation, also supports the notion that increased active site polarity alters 
the traditional catalytic scheme. 
 Based on these studies, the influence of ethanol appeared to be quite substantial, 
with the effects being more pronounced at elevated concentrations. This simulates 
conditions in vivo where humans consume larger amounts of ethanol, and the risk for 
toxic effects is increased.  However, further studies to connect these findings to 
mechanisms behind specific drug-drug interactions associated with P4502E1 would be 
even more beneficial to the toxicological profile of this isoform. 
! %(!
REFERENCES 
1. Kessova, Irina and Cederbaum, Arthur I. Curr. Mol. Med. 2003. Volume 3, Issue 6: pp. 
509-518. 
 
2. Guengerich, F. P., Kim, D. H., and Iwasaki, M. Chem. Res. Toxicol. 1991. 4: 168-179 
 
3. Koop, D. R. FASEB J. 1992. 6, 724-30. 
 
4. Collom, Samuel L. and Laddusaw, Ryan M. and Burch, Amber M. and Kuzmic, Petr 
and Perry, Martin D., Jr. and Miller, Grover P. J. Biol. Chem. 2008. 283, 6, 3487-96. 
 
5. Z. Pan, J. H. Horner, and M. Newcomb. J. Am. Chem. Soc. 2008. 130: 7776-7. 
 
6. Gupta, A., Mukherjee, A., Matsui, K., and Roth, J. P. J Am. Chem. Soc. 2008. 130: 
11274-5. 
 
7. Raner, G. M. and Chiang, E. W. and Vaz, A. D. and Coon, M. J. Biochemistry. 1997. 
36, 16, 4895-4902. 
 
8. Paine, M. F., and Oberlies, N. H. Expert Opin. Drug. Metab. Toxicol. 2007. 3, 1, 67-
80. 
 
9. Bailey, D. G., Arnold, J. M. O. and Spence, J. D. Br. J. Clin. Pharmacol. 1998. 46: 
101-110. 
 
10. Guo, L. Q., Fukuda, K., Ohta, and Yamazoe, Y. Drug Metab. Disp. 2000. 28: 766-71. 
 
11. Bailey, D. G., Spence, J. D., Edgar, B., Bayliff, C. D. and Arnold, J. M. Clin. 
Investig. Med. 1989. 12: 357-62. 
 
12. He, K., Iyer, K. R., and Hayes, R. N. Chem. Res. Toxicol. 1998. 11: 252-59.18 
 
13. Song, B. J., Gelboin, H. V., Park, S. S., Yang, C. S., and Gonzalez, F. J. J. Biol. 
Chem. 1986. 261: 16689-97. 
 
14. Song, B. J., Veech, R. L., Park, S. S., Yang, C. S., Gelboin, H. V. and Gonzalez, F. J. 
J. Biol. Chem. 1989. 264: 3568-72. 
 
15. Lee, W. M. The New England Journal of Medicine. 2003. 349 (5): 474-87. 
! %)!
16. Cederbaum, Arthur I. and Wu, Defeng and Mari, Montserrat and Bai, Jingxiang. Free 
Radical Biol. Med. 2001. 31, 12, 1539-43. 
 
17. P. R. Porubsky, K. M. Meneely, and E. E. Scott, J. Biol. Chem, 2008. 283: 33698-
33707. 
 
18. Ronis, M., Lindros, K. O., and Ingelman-Sundberg, M. 1996. Cytochromes P450, 
Metabolic and Toxicological Aspects (Ioannides, C. ed), pp. 211-239. 
 
19. Bell, L. Chastine and Guengerich, F. Peter. J. Biol. Chem. 1997. 272, 47, 29643-51. 
 
20. Bell-Parikh, L. Chastine and Guengerich, F. Peter. J. Biol. Chem. 1999. 274. 34, 
23833-40. 
 
21. Vaz, A. D. and Coon, M. J. Biochemistry. 1994. 33: 6442-6449. 
 
22. Wang, Yong and Yang, Chuanlu and Wang, Hongming and Han, Keli and Shaik, 
Sason. ChemBiochem. 2007. 8, 3, 277-81. 
 
23. Lin, Y., Lu, P., Tang, C., Mei, Q., Sandig, G., Rodrigues, D. A., Rushmore, T. H. and 
Shou, M. Drug Metab. Disp. 2001. 29 (1): 368-74. 
 
24. A. Kohen. Progress in Reaction Kinetics and Mechanism. (2003) 28: 119-15 
 
25. Principles of Inorganic Biochemistry. S. J. Lippard and J. M. Berg. (1994). 
University Science Books. 
 
26. Ezymatic Reaction Mechanisms. P. A. Frey and A. D. Hegeman. (2007). Oxford 
University Press US. 
 
27. Cleland, W. Arch. Biochem. Biophys. 2005. 433: 2-12. 
